Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Expands Approval of Osimertinib in Lung Cancer

2.

An inoperable locally advanced NSCLC trial dubbed "Practice Changing".

3.

Alkem introduces cetuximab under the trade name Cetuxa in India.

4.

Implant-based reconstruction linked to increased risk of breast lymphomas

5.

Aspirin for CRC Risk Reduction May Benefit Unhealthy People Most


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot